FDA Recalls VIDAS PRG Progesterone Test Kits for Substrate Error
bioMerieux is recalling 1,818 units of VIDAS PRG Progesterone test kits due to a substrate error that prevents the tests from running properly, causing delayed results when patients need repeat testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II device recall with a substrate error that prevents proper test execution, but no reported illnesses, injuries, or hospitalizations. The primary impact is operational—test failure requiring repeat testing—rather than direct patient harm.
Plain-English summary
bioMerieux, Inc. is recalling 1,818 units of VIDAS PRG Progesterone test kits (REF 30409-01) that are distributed nationwide across the United States.
A substrate error in these test kits prevents the tests from running properly. When this error occurs, the test cannot be completed and users must run another test to obtain results, potentially delaying diagnosis.
The FDA has classified this as a Class II recall. The affected lot numbers are 1008685490, 1008766980, 1008775630, 1008873180, and 1008911240. Healthcare facilities and laboratories that have received kits from these lots should contact bioMerieux or their supplier for replacement or further guidance.
The recalled product
- Product
- VIDAS PRG Progesterone, REF 30409-01
- Manufacturer
- bioMerieux, Inc.
- Affected units
- 1,818
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- UDI 03573026064952
- Lot #s: 1008685490
- 1008766980
- 1008775630
- 1008873180
- 1008911240
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by bioMerieux, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · bioMerieux, Inc.
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · substrate error
See all →- ModerateDiagnostic substrate error in medical testing device causes test failures
FDA (Devices) · 2022-01-05
- HighVIDAS procalcitonin diagnostic test substrate error causes testing delays
FDA (Devices) · 2022-01-05
- HighVIDAS Mumps IgG diagnostic test kit recalled due to substrate error
FDA (Devices) · 2022-01-05
- ModerateVIDAS LH diagnostic test substrate error causes delayed results
FDA (Devices) · 2022-01-05
- HighVIDAS SARS-COV-2 Diagnostic Test Recalled for Substrate Error
FDA (Devices) · 2022-01-05